Page last updated: 2024-08-17

quinoxalines and ps1145

quinoxalines has been researched along with ps1145 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adcock, IM; Caramori, G; Ito, K1
Buccinnà, B; De Marco, G; Lomartire, A; Lupino, E; Piccinini, M; Ramondetti, C; Ricotti, E; Rinaudo, MT; Tovo, PA1

Reviews

1 review(s) available for quinoxalines and ps1145

ArticleYear
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.
    Current opinion in investigational drugs (London, England : 2000), 2004, Volume: 5, Issue:11

    Topics: Anti-Inflammatory Agents; Asthma; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Imidazoles; NF-kappa B; Protein Serine-Threonine Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Quinoxalines

2004

Other Studies

1 other study(ies) available for quinoxalines and ps1145

ArticleYear
In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
    Immunology, 2010, Volume: 131, Issue:2

    Topics: Active Transport, Cell Nucleus; Antibodies, Monoclonal; Carrier Proteins; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cyclin D3; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Gene Expression; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; I-kappa B Proteins; Imidazoles; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Intracellular Signaling Peptides and Proteins; Lymphocyte Activation; NF-kappa B; NF-KappaB Inhibitor alpha; Oncogene Proteins; Protein Kinase Inhibitors; Pyridines; Quinoxalines; S-Phase Kinase-Associated Proteins; Signal Transduction; Up-Regulation

2010